韦安慧

职 称:副教授

办公地点:再生所507

办公电话:

电子信箱:weianhui@jlu.edu.cn

教育背景

2009-2012 yL23411永利官网登录yL23411永利官网登录 博士研究生 

2007-2009 yL23411永利官网登录yL23411永利官网登录 硕士研究生 

2002-2007 yL23411永利官网登录yL23411永利官网登录 本科生

工作经历

2022-至今, yL23411永利官网登录, yL23411永利官网登录, 副教授

2012-2022, yL23411永利官网登录, yL23411永利官网登录, 讲师

2018-2019, 美国罗彻斯特大学 访问学者

主讲课程

人类疾病动物模型的复制

研究领域

干细胞治疗 肿瘤靶向治疗

科研成果

(1) Huo J, Wei A, Guo N, Wang R, Bi X. The Yeast HMGB Protein Hmo1 Is a Multifaceted Regulator of DNA Damage Tolerance. Int J Mol Sci. 2025;26(7):3255.

(2) Mu X, Hu K, Wei A, Bai J, Feng L, Jiang J. TiO2 nanoparticles promote tumor metastasis by eliciting pro‑metastatic extracellular vesicles. J Nanobiotechnology. 2023;21(1):392.

(3) Fan L, Wei A, Gao Z, Mu X. Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy. Biomed Pharmacother. 2023;161:114451.

(4) Xupeng Mu, Meng Zhang, Anhui Wei, Fei Yin, Yan Wang, Kebang Hu, Jinlan Jiang. Doxorubicin and PD-L1 siRNA co-delivery with stem cell membrane-coated polydopamine nanoparticles for the targeted chemoimmunotherapy of PCa bone metastases. Nanoscale. 2021;13(19):8998-9008.

(5) Xupeng Mu, Liqun Ren, Haowen Yan, Xinmin Zhang, Tianmin Xu, Anhui Wei*. Enhanced differentiation of human amniotic fluid-derived stem cells into insulin-producing cells in vitro. J Diabetes Investig. 2017;8(1):34-43.

(6) Xupeng Mu, Kebang Hu, Mohan Shen, Ning Kong, Changhao Fu,Weiqun Yan, Anhui Wei*. Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA). J Virol Methods. 2016;228:84-90.

Baidu
sogou